Successes
Super Lawyers has again recognized the attorneys of Sheller P.C. in 2018. Founder Stephen A. Sheller has been selected by the organization for the fifteenth consecutive ...
In a significant ruling by the Pennsylvania Superior Court, Janssen, a subsidiary of Johnson & Johnson (J&J), will now face punitive damages in Risperdal mass tor...
Sheller PC's $70 Million Risperdal win hits #1 on the Top 50 Verdicts in Pennsylvania in 2016. In the case A.Y., Pro Ami v. Janssen Pharmaceuticals, Inc., a jury found ...- A Philadelphia jury awarded $500,000 in compensatory damages to a young man who claimed he grew female-like breasts after taking the antipsychotic drug Risperdal. The ...
- PHILADELPHIA, Nov. 11, 2015 /PRNewswire-USNewswire/ -- A Philadelphia jury has awarded $1.75 million to a young man who claimed his taking the antipsychotic drug Ri...
- Risperdal Accords Don't Mean Swift End to Litigation by P.J. D'Annunzio, The Legal Intelligencer After settlement of the third case to head to the courtroom in...
Stephen Sheller was honored with a Lifetime Achievement Award Wednesday, May 20 2015 from American Lawyer Media's daily newspaper, The Legal Intelligencer. The award was based on his record of verdicts and settlements, service to clients, dedication to the practice, and support of legal education. The Legal Intelligencer, May 20, 2015: "Stephen A. Sheller is the founding
American Lawyer Media’s Top Pennsylvania Verdicts and Settlements for 2014 reveals Sheller, P.C. in a familiar spot again in 2014. The firm has been at or near the top of the list for five of the last six years. This year the firm pulled both the #6 and #11 Top Settlements spots based on its legendary strength in whistleblower “qui tam” lawsuits. The #6 ranking: in September 2014, the Shel
April 27, 2010: In the third record whistleblower settlement for Sheller, P.C. in fifteen months, the firm represented a whistleblower who brought forth knowledge of wrongdoing by AstraZeneca. AstraZeneca agreed to a civil settlement of $520 million for charges of off-label marketing of the powerful antipsychotic drug Seroquel. The settlement is the largest pharmaceutical civil settlement and
Pfizer Inc. ignored a 2005 FDA warning letter to stop promoting its antibiotic Zyvox@ as clinically superior to the significantly less expensive, generic vancomycin when its own FDA-approved label indicated otherwise. The drug giant also defrauded federal and state taxpayers by marketing Zyvox@ off-label, according to a qui tam whistleblower complaint filed by Sheller, P.C. attorneys and other doc
Sheller, P.C. had the largest settlement in Pennsylvania in 2013-2014 as published in American Lawyer Media's Legal Intelligencer newspaper. The $2.2 billion settlement with Janssen Pharmaceuticals, a division of Johnson & Johnson, was a qui tam case where Sheller, P.C. represented the whistleblower who brought the qui tam charges. With the U.S. Department of Justice, the Sheller firm achieved